Keratorefrative procedures alter the corneal biomechanical properties with regard to corneal hysteresis and corneal resistant factor. The flap-based LASIK and ReLEx flex and the flap-free ReLEx smile result in similar reduction in corneal biomechanics when evaluated by Corvis ST and ORA.

Keratoconus (KC) is the most common ectatic corneal disease, with clinical findings that include discomfort, visual disturbance and possible blindness if left untreated. KC affects approximately 1:400 to 1:2000 people worldwide, including both males and females. The aetiology and onset of KC remains a puzzle and as a result, the ability to treat or reverse the disease is hampered. Sex hormones are known to play a role in the maintenance of the structure and integrity of the human cornea. Hormone levels have been reported to alter corneal thickness, curvature, and sensitivity during different times of menstrual cycle. Surprisingly, the role of sex hormones in corneal diseases and KC has been largely neglected. Prolactin-induced protein, known to be regulated by sex hormones, is a new KC biomarker that has been recently proposed. Studies herein discuss the role of sex hormones as a control mechanism for KC onset and progression and evidence supporting the view that prolactin-induced protein is an important hormonally regulated biomarker in KC is discussed.

Although the corneal deformation characteristics differed between groups of keratoconic and normal eyes, this study showed that the standard parameters of the Corvis ST cannot readily be used for diagnosis of keratoconus in the individual patient or to document the effect of CXL in vivo.

The considerable variation in repeatability and reproducibility should be taken into account when using the Corvis. Corvis parameters showed poor correlation with CH and CRF obtained by ORA measurements.